Barclays Maintains Universal Health Services(UHS.US) With Buy Rating, Maintains Target Price $257
Cantor Fitzgerald Maintains Universal Health Services(UHS.US) With Hold Rating, Maintains Target Price $227
Barclays Maintains Universal Health Services(UHS.US) With Buy Rating, Maintains Target Price $257
UBS Maintains Universal Health Services(UHS.US) With Buy Rating, Raises Target Price to $280
Universal Health (UHS) Receives a Buy From UBS
Morgan Stanley Maintains Universal Health Services(UHS.US) With Hold Rating, Maintains Target Price $200
Leerink Partners Maintains Universal Health Services(UHS.US) With Buy Rating, Raises Target Price to $252
Wells Fargo Maintains Universal Health Services(UHS.US) With Buy Rating, Maintains Target Price $225
Cantor Fitzgerald Maintains Universal Health Services(UHS.US) With Hold Rating, Maintains Target Price $227
Baird Adjusts Price Target on Universal Health Services to $243 From $224, Maintains Neutral Rating
Mizuho Securities Adjusts Universal Health Services Price Target to $242 From $240
Universal Health Services: Strong Performance and Future Potential Drive Buy Rating Amid Growth and Margin Expansion
Guggenheim Maintains Universal Health Services(UHS.US) With Buy Rating, Raises Target Price to $212
RBC Capital Maintains Universal Health Services(UHS.US) With Hold Rating, Cuts Target Price to $201
Universal Health Is Maintained at Sector Perform by RBC Capital
A Quick Look at Today's Ratings for Universal Health Services(UHS.US), With a Forecast Between $215 to $227
RBC Cuts Price Target on Universal Health Services to $201 From $211, Keeps Sector Perform Rating
Research Alert: Margin Growth, Higher Inpatient Admissions Lead Uhs To A Q1 Earnings Beat
Universal Health Is Maintained at Overweight by Barclays
Universal Health Services Analyst Ratings